FARSB

Across TCGA pan-cancer cohorts, FARSB mass-spec protein is linked to patient survival in 6 of 34 cancer types, making it a survival-associated FARSB data layer compared with 24 for mass-spec protein and 7 for mutation status.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher FARSB mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated FARSB expression acts as an unfavorable survival marker, although some lineages such as COAD and PDAC show a favorable association.

COAD, PDAC, and LSCC are the cancer types where FARSB mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Median	All	1.000	0.918	.012	78	view →
PDAC	DFS	Tertile	II,III,IV	0.508	0.174	.014	13	view →
LSCC	DFS	Tertile	II,III,IV	1.000	0.355	.006	5	view →
UCEC	DFS	Median	All	0.943	0.780	.009	4	view →
HNSC	DFS	Tertile	III,IV	0.898	0.706	.020	2	view →
GBM	OS	Quartile	All	1.000	0.853	.020	1	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

FARSB–COAD (DFS)

Open the COAD breakdown →